Biopsy Needles - India CDSCO Medical Device Registration

Biopsy Needles is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2022/000425_884fd18f01288e2fc85246752a977373_9d14bff9f667779c90e652dd48e242e1. This device is marketed under the brand name EnCor Ultra® Breast Biopsy System & EnCor Enspire® Breast Biopsy System. The license holder is Becton Dickinson India Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

Biopsy Needles

UID: IMP/MD/2022/000425_884fd18f01288e2fc85246752a977373_9d14bff9f667779c90e652dd48e242e1

Brand Name

EnCor Ultra® Breast Biopsy System & EnCor Enspire® Breast Biopsy System

License Holder

Becton Dickinson India Private Limited

Device Class

Class B

Approving Authority

CDSCO

Product Information

The EnCor Breast Biopsy System is indicated to provide breast tissue samples for diagnostic sampling of breast abnormalities. • It is intended to provide breast tissue for histologic examination with partial or complete removal of the imaged abnormality. • It is intended to provide breast tissue for histologic examination with partial removal of a palpable abnormality. The extent of a histologic abnormality cannot always be readily determined from palpation or imaged appearance. Therefore, the extent of removal of the palpated or imaged evidence of an abnormality does not predict the extent of removal of a histologic abnormality, e.g., malignancy. When the sampled abnormality is not histologically benign, it is essential that the tissue margins be examined for completeness of removal using standard surgical procedures. In instances when a patient presents with a palpable abnormality that has been classified as benign through clinical and/or radiological criteria (EnCor Ultra® Breast Biopsy System & EnCor Enspire® Breast Biopsy System), the EnCor Breast Biopsy System may also be used to partially remove such palpable lesions. Whenever breast tissue is removed, histological evaluation of the tissue is the standard of care. When the sampled abnormality is not histologically benign, it is essential that the tissue margins be examined for completeness of removal using standard surgical procedures

Class B

Biopsy Needles

Brand: Bard® Marquee® Disposable Core Biopsy Instrument Kit

Bard India Healthcare Pvt. Ltd.

Class B

Brand: CV Plus with Pigtail

Class A